Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miltefosine or Thermotherapy vs Glucantime for Cutaneous Leishmaniasis
NCT00471705Phase 3Completed
- Sponsor
- Universidad de Antioquia
- Start
- Jun 2006
- Primary completion
- Aug 2008
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of miltefosine in cutaneous leishmaniasis (CL) (3 arms), sponsored by Universidad de Antioquia. Primary endpoint: Complete Clinical Response at 6 months. Started Jun 2006; status: completed.
02
Drugs
miltefosine
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT00471705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00471705.